Schizophrenia Clinical Trial
Official title:
CSP #572 - Genetics of Functional Disability in Schizophrenia and Bipolar Illness
The purpose of this study is to detect genetic associations for the development of schizophrenia (SZ) and bipolar illness (BP) by comparing Veterans with these diseases to "psychiatrically healthy" Veterans from Veterans Health Administration medical centers. In addition, the genetic basis for functional capacity and disability in Veterans affected with SZ and BP will be assessed, as will genetic predictors of suicidality and tardive dyskinesia. Finally, we will also establish a repository which allows for future genomic studies related to SZ, BP, and related disorders or sequelae.
We propose to identify the genetic basis of Veterans developing either of two major
psychiatric (or "mental health") diseases: schizophrenia and bipolar disorder. The study
will also examine the genetic basis of disability in everyday functions (such as employment,
independent living, and self care) among the same patients. By "genetic basis," we mean how
a person's genes might be a risk for developing these illnesses or being affected by them.
We will compare information gathered from Veterans with these illnesses to "psychiatrically
healthy" Veterans. Participants will be recruited from multiple Veterans Health
Administration medical centers; the analysis of blood samples will be done in designated and
approved laboratories.
Both schizophrenia and bipolar disorder are chronic psychiatric diseases associated with
considerable lifelong disability; in particular, these illnesses are common in Veterans
served by the Veterans Health Administration. Both of these conditions are also known to be
caused in part by genes or so-called heredity; studies of the entire set of human genes
(referred to as the genome) can be a tool to identify specific reasons why certain people
develop certain conditions. In addition, patients with schizophrenia or bipolar disorder
often have difficulty functioning in the real-world-including problems in attention and
memory, or the ability to perform tasks of everyday living or have normal emotional
experiences-and these "functional impairments" may also be inherited genetically. The
current study is designed to help identify who is at higher risk for these diseases and
related problems, so that better methods to diagnose and treat the conditions can be
developed in the future.
Among other aspects of schizophrenia and bipolar disorder, suicide stands out as a very
important issue to Veterans, their families, and the Veterans Health Administration. Suicide
attempts and completed suicides are more common in Veterans with schizophrenia and bipolar
illness (compared to Veterans without these illnesses), and this tendency may be inherited
as well. Part of this study will involve determining whether specific genes might be
associated with suicidal behavior. Similarly, the study will look at the genetic basis of
side effects related to taking medications for these diseases.
For this research, participants will be recruited from VA sites that have extensive
experience in conducting projects involving psychiatric disorders. We will collect
information about the genes of these Veterans from a blood sample, and we will ask questions
about health and related factors. We will also establish a repository which allows for
future genomic studies related to SZ, BP, and related disorders or sequelae. The total study
duration is indefinite in the setting of creating a SZ and BP repository, although the
required time period for addressing the primary aims is 3.5 years. Data for a comparison
("reference") group of Veterans with medical, but not psychiatric, illnesses, will be
obtained from a research initiative entitled the "VA Million Veteran Program" (VA-MVP).
Ultimately, this study attempts to advance the state-of-the-art regarding our understanding
and treatment for two common mental health disorders affecting Veterans and will also serve
as part of a major initiative to support "personalized" healthcare. It represents a major
effort to link specific genes to illnesses, and eventually to treatments intended to relieve
suffering.
;
Observational Model: Case Control
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05039489 -
A Study on the Brain Mechanism of cTBS in Improving Medication-resistant Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT05321602 -
Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective Disorder
|
Phase 1 | |
Completed |
NCT05111548 -
Brain Stimulation and Cognitive Training - Efficacy
|
N/A | |
Completed |
NCT04503954 -
Efficacy of Chronic Disease Self-management Program in People With Schizophrenia
|
N/A | |
Completed |
NCT02831231 -
Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium
|
Phase 1 | |
Completed |
NCT05517460 -
The Efficacy of Auricular Acupressure on Improving Constipation Among Residents in Community Rehabilitation Center
|
N/A | |
Completed |
NCT03652974 -
Disturbance of Plasma Cytokine Parameters in Clozapine-Resistant Treatment-Refractory Schizophrenia (CTRS) and Their Association With Combination Therapy
|
Phase 4 | |
Recruiting |
NCT04012684 -
rTMS on Mismatch Negativity of Schizophrenia
|
N/A | |
Recruiting |
NCT04481217 -
Cognitive Factors Mediating the Relationship Between Childhood Trauma and Auditory Hallucinations in Schizophrenia
|
N/A | |
Completed |
NCT00212784 -
Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)
|
Phase 3 | |
Completed |
NCT04092686 -
A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
|
Phase 3 | |
Completed |
NCT01914393 -
Pediatric Open-Label Extension Study
|
Phase 3 | |
Recruiting |
NCT03790345 -
Vitamin B6 and B12 in the Treatment of Movement Disorders Induced by Antipsychotics
|
Phase 2/Phase 3 | |
Recruiting |
NCT05956327 -
Insight Into Hippocampal Neuroplasticity in Schizophrenia by Investigating Molecular Pathways During Physical Training
|
N/A | |
Terminated |
NCT03261817 -
A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders
|
N/A | |
Terminated |
NCT03209778 -
Involuntary Memories Investigation in Schizophrenia
|
N/A | |
Completed |
NCT02905604 -
Magnetic Stimulation of the Brain in Schizophrenia or Depression
|
N/A | |
Recruiting |
NCT05542212 -
Intra-cortical Inhibition and Cognitive Deficits in Schizophrenia
|
N/A | |
Completed |
NCT04411979 -
Effects of 12 Weeks Walking on Cognitive Function in Schizophrenia
|
N/A | |
Terminated |
NCT03220438 -
TMS Enhancement of Visual Plasticity in Schizophrenia
|
N/A |